Ignite Creation Date:
2025-12-25 @ 12:53 AM
Ignite Modification Date:
2025-12-25 @ 11:08 PM
Study NCT ID:
NCT04373967
Status:
UNKNOWN
Last Update Posted:
2020-07-08
First Post:
2020-04-28
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Study to Assess the Efficacy and Safety of Liraglutide in the Treatment of Type 2 Diabetes
Sponsor:
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-04-29
Start Date Type:
ACTUAL
Primary Completion Date:
2021-12-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2021-12-02
Completion Date Type:
ESTIMATED
First Submit Date:
2020-04-28
First Submit QC Date:
None
Study First Post Date:
2020-05-05
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-07-07
Last Update Post Date:
2020-07-08
Last Update Post Date Type:
ACTUAL